Latest news
Loading news…
HistoGeneX is provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and BELAC-accredited laboratory.
HistoGeneX was acquired by CellCarta in 2019.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
43
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Antwerp, Antwerpen, Belgium
Key People at HistoGeneX
Founder, Chief Financial Officer & Director Strategic Business Development
43
professional contacts at HistoGeneX
Contact execs at HistoGeneX →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to HistoGeneX
Loading news…
FAQs about HistoGeneX
People who checked this page also checked these
Browse the full Acquirezy directory.